Issues at End of Life
The broken line or box is meant to signify the existential element to health and illness. One should consider the total needs of the patient and not just their pain…
ONCOLOGY
Symptoms at End-of-Life of Head and Neck Cancer Patients
© Springer International Publishing Switzerland 2017Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai and Brian O’Sullivan (eds.)Critical Issues in Head and Neck Oncology10.1007/978-3-319-42909-0_19 19. Symptoms at End-of-Life of Head and Neck Cancer Patients Dirk Schrijvers1 (1)…
Quality of Life Issues
© Springer International Publishing Switzerland 2017Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai and Brian O’Sullivan (eds.)Critical Issues in Head and Neck Oncology10.1007/978-3-319-42909-0_18 18. Quality of Life Issues Susanne Singer1 (1) Division of Epidemiology and Health…
Immunotherapeutic Approaches
Mechanism Specification 1. Reduced antigen processing and presentation Downregulation or mutation of HLA class molecules 2. Tumour-permissive cytokine profile Increase of immunosuppressive cytokines: TGF-β, IL-6 Decrease of stimulatory cytokines: IL-2,…
Treatment in the Elderly
Assessment of functioning Social assessment Definition: ability to live independently at home and in the community, physical performance (mobility, balance, fall risk) Definition: adequate social support to undergo treatment Measurement:…
Salvage Surgery of Head and Neck Cancer
© Springer International Publishing Switzerland 2017Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai and Brian O’Sullivan (eds.)Critical Issues in Head and Neck Oncology10.1007/978-3-319-42909-0_12 12. Salvage Surgery of Head and Neck Cancer C. René Leemans1 (1) VU University…
Recurrent/Metastatic Head and Neck Cancer: When and How to Irradiate
Setting Outcomes Janot et al. [19] GETTEC-GORTEC phase III trial (NCT00180934) n = 130 (65 each arm) Resectable recurrent HNC Sx + postoperative reRT (vs. Sx alone) Total 60…
Patient and Treatment Factors in Concurrent Chemoradiotherapy
Fig. 11.1 Acute toxicity relative risk values (T RR) and relative max-grade values for 13 head and neck treatment groups ranked by increasing relative risk. P platinum, H hydroxyurea, 5-FU…
Treatment of Viral-Associated HNC (OPC and NPC)
© Springer International Publishing Switzerland 2017Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai and Brian O’Sullivan (eds.)Critical Issues in Head and Neck Oncology10.1007/978-3-319-42909-0_10 10. Treatment of Viral-Associated HNC (OPC and NPC) Shao Hui Huang1, Melvin L. K. Chua2, Francesca Caparrotti2 and…
Multidisciplinary Decision Making and Head and Neck Tumor Boards
Fig. 6.1 Expected emotions and reactions for the SCCHN patient Fig. 6.2 Recommended actions for the healthcare professional. DIC2 Distress Inventory for Cancer version 2, HADS Hospital Anxiety and Depression…
